LifeTech Scientific

LifeTech Scientific EBIT

The EBIT of LifeTech Scientific (1302.HK) as of Sep 27, 2026 is 214.96 M CNY. In the previous year, EBIT was 186.34 M CNY — a change of 15.36% (higher).

EBIT

214.96 MCNY

YoY

15.36%

Last updated:

In 2026, LifeTech Scientific's EBIT was 214.96 M CNY, a 15.36% increase from the 186.34 M CNY EBIT recorded in the previous year.

The LifeTech Scientific EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2021
382.57 M CNY
Jan 1, 2022
437.50 M CNY
Jan 1, 2023
383.28 M CNY
Jan 1, 2024
186.34 M CNY
Jan 1, 2025
214.96 M CNY
Jan 1, 2026 (e)
310.05 M CNY
Jan 1, 2027 (e)
361.57 M CNY
Jan 1, 2028 (e)
516.14 M CNY
The LifeTech Scientific EBIT history
YEAREBITYoY
est516.14 MCNY+42.75%
est361.57 MCNY+16.62%
est310.05 MCNY+44.23%
214.96 MCNY+15.36%
186.34 MCNY-51.38%
383.28 MCNY-12.39%
437.50 MCNY+14.36%
382.57 MCNY+24.29%
307.80 MCNY+40.12%
219.67 MCNY+14.96%
191.08 MCNY-14.58%
223.68 MCNY+74.91%
127.88 MCNY+16.34%
109.92 MCNY+89.72%
57.94 MCNY+17.96%
49.12 MCNY-13.79%
56.97 MCNY+210.03%
18.38 MCNY-54.25%
40.17 MCNY+73.11%
23.21 MCNY—
Access this data via the Eulerpool API

LifeTech Scientific Revenue

LifeTech Scientific Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.08 B CNY
382.57 M CNY
340.37 M CNY
Jan 1, 2022
1.28 B CNY
437.50 M CNY
378.62 M CNY
Jan 1, 2023
1.27 B CNY
383.28 M CNY
263.24 M CNY
Jan 1, 2024
1.30 B CNY
186.34 M CNY
222.39 M CNY
Jan 1, 2025
1.59 B CNY
214.96 M CNY
172.04 M CNY
Jan 1, 2026 (e)
1.54 B CNY
310.05 M CNY
277.40 M CNY
Jan 1, 2027 (e)
1.73 B CNY
361.57 M CNY
323.63 M CNY
Jan 1, 2028 (e)
1.95 B CNY
516.14 M CNY
462.34 M CNY

LifeTech Scientific Margins

LifeTech Scientific stock margins

The LifeTech Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LifeTech Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LifeTech Scientific.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
80.79 %
35.53 %
31.61 %
Jan 1, 2022
79.64 %
34.26 %
29.65 %
Jan 1, 2023
78.57 %
30.25 %
20.77 %
Jan 1, 2024
75.28 %
14.29 %
17.06 %
Jan 1, 2025
74.40 %
13.48 %
10.79 %
Jan 1, 2026 (e)
74.40 %
20.09 %
17.97 %
Jan 1, 2027 (e)
74.40 %
20.93 %
18.73 %
Jan 1, 2028 (e)
74.40 %
26.40 %
23.65 %

LifeTech Scientific Stock analysis

What does LifeTech Scientific do? LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing LifeTech Scientific's EBIT

LifeTech Scientific's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of LifeTech Scientific's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

LifeTech Scientific's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in LifeTech Scientific’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about LifeTech Scientific stock

EBIT of LifeTech Scientific is 214.96 M CNY in 2026.

EBIT of LifeTech Scientific changed from 186.34 M CNY to 214.96 M CNY, representing a 15.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT LifeTech Scientific since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's LifeTech Scientific historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — LifeTech Scientific

All Key Metrics — LifeTech Scientific